Medication Abuse and Dependence
Carisoprodol tablets, USP contains carisoprodol, USP a Schedule IV controlled substance. Carisoprodol has been liable to manhandle, abuse, and criminal redirection for nontherapeutic use.
Maltreatment of carisoprodol represents a danger of overdosage which may prompt passing, CNS and respiratory dejection, hypotension, seizures and different issue. Patients at high danger of carisoprodol misuse may incorporate those with delayed utilization of carisoprodol, with a background marked by medication misuse, or the individuals who use carisoprodol in mix with other mishandled drugs.
Doctor prescribed medication misuse is the deliberate non-remedial utilization of a medication, even once, for its compensating mental impacts. Illicit drug use, which creates after rehashed medicate misuse, is portrayed by a powerful urge to take a medication notwithstanding unsafe results, trouble in controlling its utilization, giving a higher need to tranquilize use than to commitments, expanded resistance, and once in a while physical withdrawal. Medication misuse and illicit drug use are independent and unmistakable from physical reliance and resistance (for instance, misuse or enslavement may not be joined by resilience or physical reliance).
Resistance is the point at which a patient’s response to an explicit dose and focus is dynamically diminished without ailment movement, requiring an expansion in the dose to keep up the equivalent. Physical reliance is described by withdrawal side effects after unexpected end or a noteworthy portion decrease of a medication. Both resilience and physical reliance have been accounted for with the drawn out utilization of carisoprodol. Revealed withdrawal side effects with carisoprodol incorporate a sleeping disorder, spewing, stomach issues, cerebral pain, tremors, muscle jerking, uneasiness, ataxia, mental trips, and psychosis. Teach patients taking extensive dosages of carisoprodol or those taking the medication for a delayed time to not suddenly stop carisoprodol.